Baltimore News Journal – Lifestyle
Author:
Egetis Therapeutics
Egetis Therapeutics to Participate in Pediatric Endocrine Society Annual Meeting 2026
April 30, 2026
Egetis Appoints Tiago Nunes as Chief Medical Officer
April 9, 2026
Egetis Announces FDA Acceptance and Priority Review of NDA for Emcitate(R) (tiratricol) for MCT8 Deficiency
March 27, 2026